CVS Health Bulks Its Board up to 16 Members, Adds Hedge Fund CEO
Leerink Adjusts Price Target on CVS Health to $57 From $63, Maintains Market Perform Rating
Engagement with major shareholder Glenview has been productive. The board of directors of cvs health (CVS.US) has added four new members.
After having "productive contact" with the activist investor Glenview Capital Management, the usa chain pharmacy operator cvs health has added four new members to its board of directors.
Today's Analyst Rating | NVIDIA Price Target Raised to $189 by Evercore, Taiwan Semiconductor Price Target Raised to $240 by Barclays
Nov 18, Wall Street analysts have updated their stock ratings today including $NVIDIA(NVDA.US)$ and $Taiwan Semiconductor(TSM.US)$.
CVS Health Shares Are Trading Higher After the Company Announced the Addition of Four New Directors to Its Board.
CVS Adds 4 New Board Members After Activist Push -- Barrons.com